Related Experiment Videos
Clinical manifestations of alpha 1-antitrypsin deficiency
1Washington University School of Medicine, St. Louis, Missouri, USA.
Gastroenterology Clinics of North America
|March 1, 1995
Insights
Alpha 1-antitrypsin deficiency is a common genetic liver disease in children, often requiring liver transplants. This review covers its symptoms, diagnosis, treatment, and underlying causes.
Area of Science:
- Hepatology
- Genetics
- Pediatrics
Background:
- Alpha 1-antitrypsin deficiency (AATD) is the leading genetic cause of pediatric liver disease.
- AATD is a primary indication for liver transplantation in children.
- Understanding AATD is crucial for managing liver complications in affected infants and children.
Purpose of the Study:
- To provide a comprehensive overview of Alpha 1-antitrypsin deficiency.
- To detail the clinical features, diagnostic approaches, and therapeutic strategies for AATD.
- To elucidate the pathogenesis of liver disease associated with AATD.
Main Methods:
- Literature review of clinical manifestations.
- Analysis of diagnostic criteria and methods.
- Summary of current and emerging treatment options.
- Review of molecular and cellular mechanisms underlying AATD pathogenesis.
Main Results:
- AATD presents with diverse clinical manifestations, primarily affecting the liver in pediatric populations.
- Diagnosis relies on genetic testing and serum AAT levels.
- Management includes supportive care, specific therapies, and, in severe cases, liver transplantation.
- Pathogenesis involves the accumulation of misfolded AAT protein in hepatocytes, leading to liver injury.
Conclusions:
- Alpha 1-antitrypsin deficiency is a significant genetic disorder with substantial pediatric liver morbidity.
- Early diagnosis and appropriate management can improve outcomes for children with AATD.
- Further research into AATD pathogenesis may reveal novel therapeutic targets.
Abstract:
Alpha 1-antitrypsin deficiency is the most common genetic cause of liver disease in infants and children and is the most common genetic disease for which liver transplantation is indicated. This article presents the clinical manifestations, diagnosis, treatment, and pathogenesis of alpha 1-antitrypsin deficiency.